Future regulatory changes such as the EU’s incoming Integrated Reporting Framework (IReF) will be seamlessly integrated into the Nasdaq AxiomSL platform ensuring timely and cost-effective ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New York ...

Nvidia (NVDA) has taken legal action against EU antitrust regulators, filing a lawsuit with the Luxembourg-based General Court over their decision to accept an Italian referral to scrutinize its ...

TARRYTOWN, N.Y., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for ...

Koninklijke Philips N.V. PHG has expanded its cloud-based radiology informatics solutions in Europe, enhancing access to AI-driven workflows and innovation. This move follows the successful ...

We recently published a list of 11 Stocks That Will Go to the Moon According to Reddit. In this article, we are going to take ...

Stock indexes retreated on Tuesday, with the S&P 500 and Nasdaq 100 falling to 4-month lows ... The European Union (EU) proposed extending 150 billion euros in loans to boost defense spending ...

Adjusted operating loss is expected to be less than $495 million. EU Approval to Merck’s Welireg for Two Indications The European Commission approved Merck’s Welireg as a monotherapy for ...

The centralized marketing authorization of KOSTAIVE is valid in all EU member states and in the ... and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew ...

Feb. 20, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO ... for use in adult patients with ATTR-CM in the EU. Preliminary results from the ongoing ATTRibute-CM open-label ...

We recently published an article titled Why These Energy Stocks are Losing This Week. In this article, we are going to take a ...

ISELIN, N.J., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United ...